We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Therapeutic potential of endoplasmic reticulum stress inhibitors in the treatment of diabetic peripheral neuropathy.
- Authors
Patel, Shivangi; Pangarkar, Arnika; Mahajan, Sakshi; Majumdar, Anuradha
- Abstract
Endoplasmic stress response, the unfolded protein response (UPR), is a homeostatic signaling pathway comprising transmembrane sensors that get activated upon alterations in ER luminal environment. Studies suggest a relation between activated UPR pathways and several disease states such as Parkinson, Alzheimer, inflammatory bowel disease, tumor growth, and metabolic syndrome. Diabetic peripheral neuropathy (DPN), a common microvascular complication of diabetes-related chronic hyperglycemia, causes chronic pain, loss of sensation, foot ulcers, amputations, allodynia, hyperalgesia, paresthesia, and spontaneous pain. Factors like disrupted calcium signaling, dyslipidemia, hyperglycemia, inflammation, insulin signaling, and oxidative stress disturb the UPR sensor levels manifesting as DPN. We discuss new effective therapeutic alternatives for DPN that can be developed by targeting UPR pathways like synthetic ER stress inhibitors like 4-PhenylButyric acid (4-PBA), Sephin 1, Salubrinal and natural ER stress inhibitors like Tauroursodeoxycholic acid (TUDCA), Cordycepin, Proanthocyanidins, Crocin, Purple Rice extract and cyanidin and Caffeic Acid Phenethyl Ester (CAPE).
- Subjects
DIABETIC neuropathies; HYPERGLYCEMIA; ENDOPLASMIC reticulum; UNFOLDED protein response; INFLAMMATORY bowel diseases; CAFFEIC acid; METABOLIC syndrome
- Publication
Metabolic Brain Disease, 2023, Vol 38, Issue 6, p1841
- ISSN
0885-7490
- Publication type
Article
- DOI
10.1007/s11011-023-01239-x